Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

An IFN regulatory factor-2 DNA-binding domain dominant negative mutant exhibits altered cell growth and gene expression

Abstract

In order to study interferon regulatory factor (IRF) family mediation of cell growth regulation, we established U937 cell lines stably transfected with a truncated form of IRF-2 lacking the transcriptional repressor domain. The truncated IRF-2 contained the DNA binding domain (DBD) and bound the ISRE. Phenotypically, the IRF-2 DBD transfectants exhibited reduced cell growth, altered morphology and increased cell death. Consistent with alterations in growth characteristics, the IRF-2 DBD transfectants constitutively expressed higher levels of the cyclin dependent kinase inhibitor p21WAF1/Cip1 than did control clones. The level of p21WAF1/Cip1 expression was positively correlated with the level of DBD expressed, as well as with the level of growth inhibition in these clones. DBD expression also correlated with expression of other members of the growth regulatory complex, cyclin dependent kinase 2 and cyclin A, but not proliferating cell nuclear antigen. These results imply active repression by IRF-2 to keep p21WAF1/Cip1 transcriptionally silent.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9

Similar content being viewed by others

Abbreviations

IFNÏ„:

interferon tau

IFNα:

interferon alpha

ISRE:

IFN-stimulated response element

DBD:

DNA-binding domain

IRF-2:

interferon regulatory factor 2

ICSBP:

interferon consensus sequence-binding protein

2′5′ OAS:

2′5′ oligoadenylate synthetase

EMSA:

electrophoretic mobility shift assay

UCR:

upstream conserved region

Cdk:

cyclin dependent kinase

PCNA:

proliferating cell nuclear antigen

References

  • Antalis TM and Godblot D . 1991 Nucl Acids Res 19: 4301

  • Beretta L, Gabbay M, Berger R, Hanash SM and Sonenberg N . 1996 Oncogene 12: 1593–1596

  • Biggs JR, Kudlow JE and Kraft AS . 1996 J Biol Chem 271: 901–906

  • Chin YE, Kitagawa M, Su WS, You ZH, Iwamoto Y and Fu XY . 1996 Sci 272: 719–722

  • Darnell Jr JE, Kerr IM and Stark G . 1994 Science 264: 1415–1420

  • El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parson R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B . 1993 Cell 75: 817–825

  • Flanagan JR, Becker KG, Ennist DL, Gleason SL, Driggers PH, Levy B, Appella E and Ozato K . 1992 Mol Cell Biol 12: 38–44

  • Gao SJ, Boshoff C, Jayachandra S, Weiss RA, Chang Y and Moore PA . 1997 Oncogene 15: 1979–1985

  • Harada H, Kitagawa M, Tanaka N, Yamamoto H, Harada K, Ishihara M and Taniguchi T . 1993 Science 259: 971–974

  • Harada H, Taniguchi T and Tanaka N . 1998 Biochimie 80: 641–650

  • Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ . 1993 Cell 75: 805–816

  • Hassel BA, Zhou A, Sotomayor C, Maran A and Silverman RW . 1993 EMBO J 12: 3297–3304

  • Kirchhoff S, Schaper F and Hauser H . 1993 Nuc Acids Res 21: 2881–2889

  • Koromilas AE, Roy S, Barber GN, Katze MG and Sonenberg N . 1992 Science 257: 1685–1689

  • LaBaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A and Harlow E . 1996 Genes Dev 11: 847–862

  • Lamphier M and Taniguchi T . 1994 The Immunologist 2/5: 167–171

  • Liu M, Lee M-H, Cohen M, Bommakanti M and Freedman LP . 1996 Genes Dev 10: 142–153

  • Macleod FK, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B and Jacks T . 1995 Genes Dev 9: 935–944

  • Matsuyama T, Kimura T, Kitagawa M, Pfeffer K, Kawakami T, Watanabe N, Kundig TM, Amakawa R, Kishihara K, Wakeham A, Potter J, Furlonger CL, Narendran A, Suzuki H, Ohashi PS, Paige CJ, Taniguchi T and Mak TW . 1993 Cell 75: 83–97

  • Meurs EF, Galabru J, Barber GN, Katze MG and Hovanessian AG . 1993 Proc Natl Acad Sci USA 90: 232–236

  • Niwa H, Yamamura K and Miyazuki J . 1991 Gene 108: 193–199

  • Pestka S, Langer JA, Zoon KC and Samuel CE . 1987 Annu Rev Biochem 56: 727–777

  • Pitha PM, Au W-C, Lowther W, Juang Y-T, Schafer SL, Burysek L, Hiscott J and Moore PA . 1998 Biochimie 80: 651–658

  • Rysiecki G, Gewert DR and Williams BRG . 1989 J Interferon Res 9: 649–657

  • Schreiber E, Matthias P, Muller MM and Schaffner W . 1989 Nucleic Acids Res 17: 6419

  • Stewart HJ, McCann SHE, Barker PJ, Lee KE, Lamming GE and Flint APF . 1987 J Endocrinol 115: R13–R15

  • Subramaniam PS and Johnson HM . 1997 J Interferon Res 17: 11–15

  • Sugimoto K, Toyoshima H, Sakai R, Miyagawa K, Hagiwara K, Ishikawa F, Takaku F, Yazaki Y and Hirai H . 1992 Blood 79: 2378–2383

  • Tanaka N, Ishihara M, Kitagawa M, Harada H, Kimura T, Matsuyama T, Lamphier MS, Aizawa S, Mak TW and Taniguchi T . 1994 Cell 77: 829–839

  • Tanaka N, Kawakami T and Taniguchi T . 1993 Mol Cell Biol 13: 4531–4538

  • Taniguchi T, Harada H and Lamphier M . 1995 J Cancer Res Clin Oncol 121: 516–520

  • Thornton AM, Ogryzko VV, Dent A, Sharf R, Levi B-Z, Kanno Y, Staudt LM, Howard BH and Ozato K . 1996 J Immunol 157: 5145–5154

  • Wolffe AP . 1994 Science 264: 1100–1101

  • Xiong Y, Hannon GJ, Zhang H, Casso D, Kobaysahi R and Beach D . 1993 Nature 366: 701–704

  • Zhang H, Hannon GJ and Beach D . 1994 Genes Dev 8: 1750–1758

  • Zhang W, Grasso L, McClain CD, Gambel AM, Cha Y, Travali S, Deisseroth AB and Mercer WE . 1995 Cancer Res 55: 668–674

Download references

Acknowledgements

We thank Drs Mark Hayes and Joy Williams (Food and Drug Administration) for their insightful manuscript review. This work was supported in part by a predoctoral fellowship to YR Rubinstein from the National Institute of Child Health and Development and in part by American Heart Association grant 94011550 to CH Pontzer.

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rubinstein, Y., Driggers, P., Ogryzko, V. et al. An IFN regulatory factor-2 DNA-binding domain dominant negative mutant exhibits altered cell growth and gene expression. Oncogene 19, 1411–1418 (2000). https://doi.org/10.1038/sj.onc.1203435

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/sj.onc.1203435

Keywords

This article is cited by

Search

Quick links